Stannsoporfin: Completed Phase IIb enrollment

InfaCare completed enrollment of 91 term and near-term newborns in the double-blind, placebo-controlled, U.S. Phase IIb Jasmine trial comparing 3 and 4.5 mg/kg intramuscular stannsoporfin with phototh...